Product Information
LEVETIRACETAM 250 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0599 per EA under NDC 67877076812. Its NADAC has been published 187 times since Nov 30, 2022.
Strength
250 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877076812
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA216375On Market Since
5/28/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 250 MG TABLET has been published 187 times since Nov 30, 2022, and over the history we have for it it has declined 16.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0599 per EA |
|---|---|
| All-time high | $0.0740 (Dec 13, 2023) |
| All-time low | $0.0454 (Nov 20, 2024) |
| 52-week high | $0.0638 |
| 52-week low | $0.0562 |
| Median price | $0.0627 |
| Average price | $0.0619 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 187 |
| Tracking since | Nov 30, 2022 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0599 per EA (NDC 67877076812), effective Jun 24, 2026.
How has the price of LEVETIRACETAM 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has declined 16.1%. It has been tracked across 187 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?
Since Nov 30, 2022, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0454 (Nov 20, 2024) to a high of $0.0740 (Dec 13, 2023), with a median of $0.0627 per EA.
Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?
Yes. 17 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 18% below LEVETIRACETAM 250 MG TABLET.
Who manufactures LEVETIRACETAM 250 MG TABLET?
LEVETIRACETAM 250 MG TABLET (NDC 67877076812) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification